Nu-Med Plus (NUMD) EBIT (QoQ) (2013 - 2025)
Nu-Med Plus (NUMD) EBIT (QoQ) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn |
| 2 | Stryker | 129.55 Bn | 126.07 Bn | 4.50 Bn |
| 3 | Medtronic | 119.60 Bn | 110.38 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.64 Bn | 73.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.33 Bn | 48.08 Bn | 1.35 Bn |
| 6 | Dexcom | 34.69 Bn | 32.74 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.12% |
| Sep 30, 2025 | 3.30% |
| Jun 30, 2025 | 44.28% |
| Mar 31, 2025 | -101.21% |
| Dec 31, 2024 | 46.64% |
| Sep 30, 2024 | -8.58% |
| Jun 30, 2024 | 22.06% |
| Mar 31, 2024 | 62.81% |
| Dec 31, 2023 | -265.35% |
| Sep 30, 2023 | 34.36% |
| Jun 30, 2023 | 14.45% |
| Mar 31, 2023 | -321.82% |
| Dec 31, 2022 | 88.99% |
| Sep 30, 2022 | 0.03% |
| Jun 30, 2022 | 2.65% |
| Mar 31, 2022 | 46.90% |
| Dec 31, 2021 | 5.09% |
| Sep 30, 2021 | 53.03% |
| Jun 30, 2021 | 29.36% |
| Mar 31, 2021 | 29.42% |